The Drug Enforcement Administration (DEA) will call for cannabis to be rescheduled according to a report by the Associated Press. The anticipated rescheduling follows the Department of Health & Human Services’ (HHS) August...more
5/3/2024
/ Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Controlled Substances ,
Controlled Substances Act ,
Corporate Counsel ,
DEA ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Internal Revenue Code (IRC) ,
Legalization ,
Marijuana ,
Medical Devices ,
Plant Based Products ,
Popular ,
Recreational Use ,
Regulatory Reform ,
Retail Market ,
Schedule I Drugs ,
Trademark Application ,
USPTO